ARS Investment Partners’s IRIDEX IRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-110,060
Closed -$185K 200
2025
Q1
$185K Hold
110,060
0.02% 163
2024
Q4
$185K Sell
110,060
-3,505
-3% -$5.78K 0.02% 164
2024
Q3
$199K Hold
113,565
0.02% 160
2024
Q2
$245K Buy
113,565
+3,500
+3% +$9.38K 0.02% 135
2024
Q1
$328K Buy
110,065
+323
+0.3% +$873 0.03% 119
2023
Q4
$308K Buy
109,742
+38,250
+54% +$100K 0.03% 123
2023
Q3
$182K Buy
+71,492
New +$136K 0.02% 142

Other funds holding IRIX

ARS Investment Partners's IRIX Position: Q2 2025 in Review

ARS Investment Partners sold out of IRIDEX (IRIX) in Q2 2025, closing a stake of 110,060 shares — an estimated $185K sold.

ARS Investment Partners first reported a position in IRIX in Q3 2023 and held it in 7 quarters. The position peaked at $328K in Q1 2024. 20 funds tracked by Wall St. Rank hold IRIX as of Q2 2025.

  • ARS Investment Partners reported no remaining IRIDEX position as of Q2 2025 after selling out during the quarter.
  • ARS Investment Partners sold 110,060 IRIDEX shares in Q2 2025, an estimated $185K.
  • ARS Investment Partners first reported a position in IRIDEX in Q3 2023 and held it in 7 quarters.
  • ARS Investment Partners's IRIDEX position peaked at $328K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held IRIDEX as of Q2 2025.

Based on ARS Investment Partners's 13F filing for Q2 2025, filed 11 Aug 2025.